Abstract
Reliance on market forces can lead to underinvestment in social welfare enhancing innovation. The lack of new medical products in the area of neglected diseases is a case in point. R&D for neglected diseases has increased with new funding and collaborations taking place mainly through product development partnerships (PDPs). PDPs are self-governing, private non-profit R&D organizations. In contrast to push and pull instruments designed to address private-sector R&D underinvestment, PDPs have emerged voluntarily to address this public health challenge. In this study we examine how non-profit R&D collaboration for neglected diseases takes place through PDPs. We find that PDPs act as 'system integrators' that leverage the resources and capabilities of a network of public, philanthropic and private-sector partners. This paper contributes to an understanding of R&D in a non-profit context and highlights the importance of collaboration and nonmarket institutions for promoting innovation where market failures occur.
Original language | English |
---|---|
Pages (from-to) | 315-338 |
Number of pages | 24 |
Journal | Science and Public Policy |
Volume | 42 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1 Jun 2015 |
Keywords
- Innovation
- Neglected diseases
- Non-profit
- R&D collaboration
ASJC Scopus subject areas
- Geography, Planning and Development
- Public Administration
- Management, Monitoring, Policy and Law